(Q37938361)

25 August 2017

The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma (English)

1 reference

25 August 2017

Edward J Tanner

1

0 references

Dennis Chi

series ordinal

4

object named as

Dennis S Chi

1 reference

25 August 2017

7

Richard R Barakat

1 reference

25 August 2017

5

Yukio Sonoda

1 reference

25 August 2017

6

Ginger J Gardner

1 reference

25 August 2017

8

Elizabeth L Jewell

1 reference

25 August 2017

Mario M Leitao

2

1 reference

PubMed ID

21945551

25 August 2017

Karuna Garg

series ordinal

3

1 reference

PubMed ID

21945551

25 August 2017

language of work or name

English

0 references

publication date

25 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

123

1 reference

25 August 2017

3

1 reference

25 August 2017

548-552

1 reference

Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Prognostic features of surgical stage I uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Analysis of clinicopathologic factors in malignant mixed Müllerian tumors of the uterine corpus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Clinicopathologic analysis of uterine malignant mixed müllerian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Role of cytoreduction in stage III and IV uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Weichgewebssarkome – prognostische Faktoren und multimodale Therapie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.020

10.1016/J.YGYNO.2011.08.020

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21945551